Dr. Jiangyang Zhang's lab at NYU School of Medicine focuses on understanding and developing treatments for neonatal hypoxic ischemic injury, a serious condition affecting infants. They use advanced imaging techniques to study how this injury affects brain tissue and to evaluate the effectiveness of therapeutic hypothermia. By creating detailed models and measurements, the lab aims to innovate ways to diagnose and monitor brain injuries in newborns, ultimately leading to better intervention strategies.

Dr. Jakob Asslaender's lab focuses on developing advanced MRI techniques to enhance the accuracy of imaging in clinical settings, particularly for neurological diseases like multiple sclerosis. The research aims to improve the objectivity and comparability of MRI data by refining a specialized imaging model that reduces scan times while boosting the sensitivity and specificity of results. This work is vital for advancing precision medicine and ensuring better diagnosis and treatment planning in neurology.

Dr. Ralph J. Diclemente's lab at New York University focuses on public health issues, particularly those affecting pregnant women. The lab conducts research to develop and evaluate interventions that aim to reduce alcohol consumption during pregnancy to prevent fetal alcohol spectrum disorders. By collaborating with various universities and healthcare institutions, the lab is dedicated to improving prenatal care and reducing alcohol-related birth complications.

Dr. Lauren Krupp's lab at NYU focuses on understanding how childhood adversities affect health outcomes in individuals with multiple sclerosis (MS), particularly among communities that are often underrepresented in medical research. The lab works directly with patients from diverse backgrounds to develop culturally informed research tools and interventions aimed at improving quality of life for people living with MS. By addressing health disparities and fostering community engagement, the lab seeks to ensure that all individuals with MS can access better care and support.

Dr. Jesús Torres-Vázquez's lab investigates the mechanisms behind how blood vessels achieve their proper size and structure, which is crucial for maintaining effective blood circulation. Using zebrafish as a primary model organism, the lab studies the signaling pathways and cellular processes that influence blood vessel caliber, including the roles of specific proteins and the effects of blood flow. Research in this lab aims to improve our understanding of cardiovascular health and the effects of vascular abnormalities.

Dr. Jessica E. Treisman's lab focuses on understanding the development and function of the corneal lens in the fruit fly Drosophila. By studying how specific cells in the retina differentiate and form the cornea, the lab aims to uncover mechanisms that could be relevant to human vision disorders like myopia and keratoconus. Their research combines genetic techniques and advanced imaging to explore cellular and molecular processes, providing insights that may help develop treatments for corneal diseases.

Dr. Richard W. Tsien's lab at NYU focuses on understanding how calcium channels in neurons influence learning and memory, particularly through a process called excitation-transcription coupling. They also investigate how oxytocin, a hormone related to social behaviors, affects the brain's neural circuits and may help with conditions like autism. By integrating biology, behavioral science, and advanced techniques, the lab aims to uncover mechanisms that link neuronal activity to behavioral outcomes.

Dr. Jun Wang's lab at New York University focuses on understanding the mechanisms by which certain proteins in the tumor microenvironment suppress the immune system's ability to fight cancer. They are particularly interested in the roles of Siglec-15 and FGL1, two proteins that can inhibit T cell responses and promote tumor growth. By studying these proteins, the lab aims to develop new immunotherapies that can improve treatment outcomes for cancer patients who do not respond well to existing therapies.

Dr. Alexander S. Bennett's lab focuses on understanding and improving the health outcomes of military veterans affected by the opioid crisis. This research seeks to evaluate and implement community-based interventions that reduce opioid-related harms, particularly among those veterans who are not connected to traditional healthcare systems. By utilizing peer support and educational components, the lab aims to empower veterans to engage with healthcare options, ultimately improving their well-being and reducing risks associated with opioid use.

Dr. Angus C. Wilson's lab studies how viruses, particularly the herpes simplex virus (HSV-1), manipulate host cell functions to enhance their replication. They explore the ways HSV-1 disrupts the host's genetic processes, particularly focusing on RNA processing and the cellular responses to stress that can trigger virus reactivation. Through their research, they hope to uncover new strategies to develop antiviral therapies against viral infections and understand their impact on the nervous system.

Dr. Marcelo Victor Wust Zibetti's lab focuses on developing advanced imaging techniques to improve the early diagnosis of knee osteoarthritis, a common disability among older adults. The research emphasizes the use of magnetic resonance imaging (MRI) to assess cartilage health by analyzing structures non-invasively. This work aims to create faster and more accurate imaging methods to identify changes in cartilage before physical symptoms arise, ultimately contributing to better prevention strategies for knee osteoarthritis.

Dr. Itai Yanai's lab at New York University School of Medicine focuses on understanding how cancer cells adapt to treatment, specifically studying the transition from lung adenocarcinoma to squamous cell carcinoma in response to specific drugs like adagrasib. By exploring molecular mechanisms and chromatin regulators involved in this process, the lab aims to uncover new therapeutic strategies to counteract drug resistance in lung cancer. Their research combines advanced genetic screening techniques with mouse and organoid models to identify vulnerabilities in cancer cells.

Dr. Holger Knaut's lab at NYU School of Medicine focuses on understanding how skin repairs itself after injuries and how neuronal tissues migrate and split during development. They use zebrafish embryos for their research because these embryos are transparent, allowing for high-resolution imaging. By studying the molecular mechanisms behind wound healing and nerve formation, the lab aims to provide insights into potential treatments for skin disorders and neurological diseases.